These compounds were able to inhibit in vitro the enzymes cyclooxygenase-2 (COX-2), an enzyme responsible for inflammation, and phosphoinositide-3 kinase (PI3K), a crucial enzyme in breast cancer. This evidence concerns the gene PTGS2 and breast carcinoma.